Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation

Digestive Diseases and Sciences

Volumn 55, Issue 11, 2010, Pages 3224-3234

  Schmitt, Timothy M ^a   Phillips, Melissa ^a   Sawyer, Robert G ^a   Northup, Patrick ^a   Hagspiel, Klaus D ^a   Pruett, Timothy L ^a   Bonatti, Hugo J R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Anti thymocyte globulin; Infection; Liver transplantation; Recurrent hepatitis C; Rejection

Indexed keywords

BILIRUBIN; DACLIZUMAB; DIPHENHYDRAMINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; RNA; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BLEEDING; BOLUS INJECTION; CHOLANGITIS; CHRONIC DIARRHEA; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DEEP VEIN THROMBOSIS; DRUG RESISTANCE; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; NONALCOHOLIC FATTY LIVER; PANCYTOPENIA; PNEUMONIA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; THROMBOCYTOPENIA; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; ANTILYMPHOCYTE SERUM; FEMALE; GRAFT REJECTION; HEPACIVIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; YOUNG ADULT;

EID: 78149357408     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1149-x     Document Type: Article

References (35)

1. H Andreu A Rimola M Bruguera, et al. 2002 Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy Transplantation 73 1936 1943 10.1097/00007890-200206270-00016 12131692
2. DB Kaufman R Shapiro MR Lucey WSRTB Cherikh DB Dyke 2004 Immunosuppression: practice and trends Am J Transplant 4 9 38 53 10.1111/j.1600-6135.2004.00397.x 15113354 (Pubitemid 38858994)
3. R Shapiro JB Young EL Milford JF Trotter RT Bustami AB Leichtman 2005 Immunosuppression: evolution in practice and trends, 1993-2003 Am J Transplant 5 874 886 10.1111/j.1600-6135.2005.00833.x 15760415
4. CB Ramirez C Doria F di Francesco M Iaria Y Kang IR Marino 2007 Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months J Surg Res 138 198 204 1:CAS:528:DC%2BD2sXis1yit7o%3D 10.1016/j.jss.2006.08.025 17292404 (Pubitemid 46365728)
5. AJ Bathgate P Hynd D Sommerville PC Hayes 1999 The prediction of acute cellular rejection in orthotopic liver transplantation Liver Transpl Surg 5 475 479 1:STN:280:DC%2BD3c%2FhsFaqtQ%3D%3D 10.1002/lt.500050608 10545533
6. GA Berlakovich S Rockenschaub S Taucher K Kaserer F Muhlbacher R Steiniger 1998 Underlying disease as a predictor for rejection after liver transplantation Arch Surg 133 167 172 1:STN:280:DyaK1c7ktlamug%3D%3D 10.1001/archsurg.133.2.167 9484729 (Pubitemid 28092916)
7. F Conti B Dousset D Archambeau A Louvel D Houssin Y Calmus 1995 Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients Transplantation 60 1104 1108 1:CAS:528:DyaK28XotVSjtQ%3D%3D 10.1097/00007890-199511270-00008 7482716
8. O Farges F Saliba H Farhamant, et al. 1996 Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins Hepatology 23 240 248 1:STN:280:DyaK287mt1SntA%3D%3D 10.1002/hep.510230207 8591847
9. LR Fisher KS Henley MR Lucey 1995 Acute cellular rejection after liver transplantation: variability, morbidity, and mortality Liver Transpl Surg 1 10 15 1:STN:280:DyaK1c%2FgtlWguw%3D%3D 10.1002/lt.500010104 9346535
10. DF Mirza BK Gunson Z Soonawalla, et al. 1997 Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression Lancet 349 701 702 1:STN:280:DyaK2s3jt12ksQ%3D%3D 10.1016/S0140-6736(05)60138-9 9078209 (Pubitemid 27107756)
11. CA Seiler JF Dufour EL Renner, et al. 1999 Primary liver disease as a determinant for acute rejection after liver transplantation Langenbecks Arch Surg 384 259 263 1:STN:280:DyaK1MzmsVejsA%3D%3D 10.1007/s004230050201 10437614 (Pubitemid 29309069)
12. RH Wiesner AJ Demetris SH Belle, et al. 1998 Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome Hepatology 28 638 645 1:STN:280:DyaK1cvgtVakug%3D%3D 10.1002/hep.510280306 9731552
13. N Assy PC Adams P Myers, et al. 2007 Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid Transplantation 83 1571 1576 1:CAS:528:DC%2BD2sXmslynsrk%3D 10.1097/01.tp.0000266678.32250.76 17589339 (Pubitemid 46987908)
14. N De Ruvo A Cucchetti A Lauro, et al. 2005 Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation Transplantation 80 8 12 10.1097/01.TP.0000164349.54297.95 16003226 (Pubitemid 40980888)
15. M Bahra UP Neumann D Jacob JM Langrehr P Neuhaus 2005 Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss Transplant Proc 37 1700 1702 1:CAS:528: DC%2BD2MXks1Crsrw%3D 10.1016/j.transproceed.2005.03.081 15919436 (Pubitemid 40790801)
16. RR Razonable 2008 Cytomegalovirus infection after liver transplantation: current concepts and challenges World J Gastroenterol 14 4849 4860 10.3748/wjg.14.4849 18756591
17. HR Rosen CR Shackleton L Higa, et al. 1997 Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1453 1457 1:STN:280:DyaK2svmtFersg%3D%3D 9317061
18. ML Fernandes YM Lee D Sutedja, et al. 2005 Treatment of steroid-resistant acute liver transplant rejection with basiliximab Transplant Proc 37 2179 2180 1:CAS:528:DC%2BD2MXltlWqurk%3D 10.1016/j.transproceed.2005.03.030 15964372 (Pubitemid 40956405)
19. DW Orr BC Portmann AS Knisely, et al. 2005 Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation Transplant Proc 37 4373 4379 1:CAS:528:DC%2BD28XktlGm 10.1016/j.transproceed.2005.10.022 16387124 (Pubitemid 43016035)
20. JD Eason J Blazek A Mason S Nair GE Loss 2001 Steroid-free immunosuppression through thymoglobulin induction in liver transplantation Transplant Proc 33 1470 1471 1:STN:280:DC%2BD3M7mvV2hug%3D%3D 10.1016/S0041-1345(00)02556-2 11267378 (Pubitemid 32237931)
21. JD Eason GE Loss J Blazek S Nair AL Mason 2001 Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial Liver Transpl 7 693 697 1:STN:280: DC%2BD3MvmsVOksg%3D%3D 10.1053/jlts.2001.26353 11510013 (Pubitemid 32771467)
22. JD Eason S Nair AJ Cohen JL Blazek GE Loss Jr 2003 Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy Transplantation 75 1396 1399 1:CAS:528:DC%2BD3sXjt1alt7w%3D 10.1097/01.TP.0000062834.30922.FE 12717237 (Pubitemid 36513055)
23. T Kato JJ Gaynor H Yoshida, et al. 2007 Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year Transplantation 84 829 835 1:CAS:528:DC%2BD2sXhtlaqtbbN 10.1097/01.tp.0000282914.20578.7b 17984834 (Pubitemid 351338942)
24. T Soliman H Hetz C Burghuber, et al. 2007 Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation Liver Transpl 13 1039 1044 10.1002/lt.21185 17600336 (Pubitemid 47189018)
25. T Soliman H Hetz C Burghuber, et al. 2007 Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation Transpl Int 20 447 452 1:CAS:528:DC%2BD2sXlsVSmu7Y%3D 10.1111/j.1432-2277.2007.00463.x 17343686 (Pubitemid 46535988)
26. CG Bijleveld IJ Klompmaker AP van den Berg, et al. 1996 Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation Transpl Int 9 570 575 1:STN:280: DyaK2s%2FntFeisA%3D%3D 8914237
27. AJ Demetris K Ruppert I Dvorchik, et al. 2002 Real-time monitoring of acute liver-allograft rejection using the Banff schema Transplantation 74 1290 1296 1:STN:280:DC%2BD38nptVOqtw%3D%3D 10.1097/00007890-200211150-00016 12451268
28. A Demetris D Adams C Bellamy, et al. 2000 Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel Hepatology 31 792 799 1:STN:280:DC%2BD3c7nt1Sgug%3D%3D 10.1002/hep.510310337 10706577
29. AJ Demetris EC Seaberg KP Batts, et al. 1998 Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database Am J Surg Pathol 22 28 39 1:STN:280:DyaK1c%2Fot1OktA%3D%3D 10.1097/00000478-199801000-00004 9422313 (Pubitemid 28016749)
30. KP Batts J Ludwig 1995 Chronic hepatitis. An update on terminology and reporting Am J Surg Pathol 19 1409 1417 1:STN:280:DyaK28%2FotlKkug%3D%3D 10.1097/00000478-199512000-00007 7503362
31. P De WO Bechstein G Blumhardt D Lange N Schattenfroh P Neuhaus 1993 Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? Transplant Proc 25 2693 2694 1:STN:280:DyaK3szmt1eiug%3D%3D 7689279 (Pubitemid 23239601)
32. R Hirose JP Roberts D Quan, et al. 2000 Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation Transplantation 69 307 311 1:CAS:528:DC%2BD3cXhtV2ku7k%3D 10.1097/00007890- 200001270-00019 10670644
33. UP Neumann T Berg M Bahra, et al. 2004 Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 226 231 10.1097/01.TP.0000101738.27552.9D 14742986 (Pubitemid 38155751)
34. M Berenguer M Prieto J Cordoba, et al. 1998 Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection J Hepatol 28 756 763 1:CAS:528:DyaK1cXmvVWltLo%3D 10.1016/S0168-8278(98)80224-9 9625309 (Pubitemid 28223478)
35. JR Burton Jr HR Rosen 2006 Acute rejection in HCV-infected liver transplant recipients: The great conundrum Liver Transpl 12 S38 S47 10.1002/lt.20944 17051562 (Pubitemid 44742524)